Researchers studied mitochondrial dynamics to treat Parkinson disease | Current Affairs | Vision IAS
News Today Logo

    Researchers studied mitochondrial dynamics to treat Parkinson disease

    Posted 02 Sep 2024

    2 min read

    Parkinson’s disease is a neurodegenerative disease caused by the death of brain cells.

    • Presence of environmental toxins and toxic proteins, causes fragmentations and dysfunctions in mitochondria.  E.g. Manganese induced Parkinsonism.
    • Researchers have found that inhibiting Dynamin-related protein (Drp1) activity could restore mitochondrial function and serve as a potential treatment. 
      • Naturally abundant in cells, Drp1 protein travels to mitochondria when they divide into smaller sizes for higher mobility and quality control. 
      • However, too much Drp1 activity causes excessive division, leading to fragmented mitochondria with impaired function.

    Mitochondria

    • Mitochondria are membrane-bound cell organelles that generate most of the cell's energy in the form of ATP (adenosine triphosphate).
    • Functions
      • Energy Production: Sites of aerobic respiration, producing ATP, hence termed the power houses of the cell.
      • Genetic Material: Contains its own circular DNA (Mitochondrial DNA or mtDNA), RNA, ribosomes, and components for protein synthesis. 
        • mtDNA is useful for tracing genetic lines.

    Mitochondrial Diseases

    • These are caused by genetic mutation of mtDNA or nuclear DNA. 
      • mtDNA is inherited exclusively from the mother, making these diseases maternally inherited.
      • Mitochondrial Replacement Therapy (MRT) prevents the transmission of mitochondrial diseases from mother to child.

     

    • Tags :
    • Mitochondria
    • Parkinson's Disease
    Watch News Today
    Subscribe for Premium Features

    Quick Start

    Use our Quick Start guide to learn about everything this platform can do for you.
    Get Started